Category — Healthcare

Smith and Nephew Brings its Navio Surgical System to India

With its acquisition of Blue Belt Technologies, a global leader in surgical robotics, the U.K.-based medical equipment manufacturer Smith & Nephew will introduce Blue Belt’s Navio surgical system in India for the first time.

This surgical system currently provides robotics-assistance in unicondylar or partial knee replacement surgery through CT-free navigation software and a unique hand-held, robotic bone-shaping device.

Navio Surgical System

Navio Surgical System

The company intends to expand the Navio platform into total knee, bi-cruciate retaining knee, and revision knee implants, reports Business Standard.

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter

May 22, 2016   No Comments

Baxter Close to Acquiring Gland Pharma in India

Deerfield, IL-based Baxter, which specializes in parenteral nutrition and intravenous solutions is one of two companies that have bid for Hyderabad, India-based Gland Pharma, a contract manufacturer of generic injectables. Baxter is being represented by Citigroup. The other company in the running is the Shanghai Fosun Pharmaceutical (Group) Co. Ltd, a Hong Kong-listed company, reports Live Mint.

Economic Times says that multiple sources have valued the deal at $1.1 to $1.2 billion. Private equity firm KKR and Co. owns a 40% stake in Gland Pharma, while the rest is held by the founders of Gland Pharma led by Ravi Penmetsa. Sources also claim that the owners were hoping to get $1.5 billion for Gland and that Baxter was seen as the front-runner.

Baxter

The global generic injectables market is $17 billion and is of significant importance in the value chain,” said Narayan Shetkar, director, Singhi Advisors, a Mumbai-based boutique investment bank. Given supply constraints, most global companies would be very interested in buying a maker of generic injectables and pay a sizeable premium, he added.

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter

May 22, 2016   No Comments

Philips May Create Venture Fund For India’s Healthtech Startups

Royal Philips, based in Netherlands, is looking to invest globally in venture efforts to support healthcare technology startups. Its latest could be slated for India, the company’s Jeroen Tas, CEO of Philips Health Informatics, Solutions and Services, told The Economic Times.

Jeroen Tas

Jeroen Tas

Tas did not share specific details of the proposed new venture fund, but said it would be along similar lines of the fund the company set up in Israel. In July last year, Philips and Israel-based pharma company Teva jointly set up a $30-million venture fund to invest in medical devices and healthcare technology startups in Israel over eight years

Tas added that he will be attending pitching sessions from Indian startups on his next visit to India.

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter

May 22, 2016   No Comments

India’s Practo Technologies and Twitter Tie Up

Practo Technologies Pvt. Ltd, India’s largest doctor discovery portal, has partnered with microblogging platform Twitter to enable users get their healthcare queries answered in real time by doctors.

The service has been launched in three countries—India, the Philippines and Singapore—and will be gradually rolled out in other locations reports Live Mint.

Practo TEchnologies

Practo Technologies

Since last year, Practo has launched additional services such as doctor consultation and medicine delivery, emphasizing on content with health feeds, and even entering the beauty and wellness segment.

“Twitter’s real-time, public and conversational capabilities helps people connect with things that matter, big and small. Our customer service partnerships are designed to improve user experience and access to daily utility such as real-time train schedules, pollution data, and customer care from brands. We are excited about our partnership with Practo,” said Ravichandran Bhaskaran, head of businesRavis development, India and South Asia, Twitter.

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter

May 22, 2016   No Comments

BD India Will Market Malaria Detection Platform

New Jersey-based Becton, Dickinson and Company’s India affiliate BD India has signed a deal with Israel’s Sight Diagnostics by which it will market SightDX’s Parasight Malaria Detection Platform in India, reports India Medical Times. Varun Khanna, managing director, BD India and South Asia, said, “Our collaboration with Sight Diagnostics is aligned with our purpose of advancing the world of health by bringing technology solutions for malaria diagnosis to India.”

Parasight Platform

Parasight Platform

According to Sight Diagnostics, the Parasight device is a platform for blood analysis. When used with the Malaria test kit, it combines computer-vision algorithms (image processing) to rapidly identify and quantify blood components (e.g. red blood cells) and blood anomalies (e.g. parasites) in an automated fashion, and in less than 4 minutes, a report is created with the diagnosis (Positive/Negative), parasitemia count (percentage of infected red blood cells), and speciation (determination of the specific species of malaria)

Yossi Pollak, CEO, SightDX, said, “Our collaboration with BD provides us with an established and experienced partner in the field of infectious disease, and together we can better serve the Indian healthcare market.”

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter

May 3, 2016   No Comments